Double-dose icotinib may induce the emergence of the EGFR exon 20 T790M mutation in non-small cell lung cancer patients harboring EGFR-sensitive mutation

BACKGROUND: Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) inevitably occurs in non-small cell lung cancer (NSCLC) patients harboring EGFR-sensitive mutations. There are approximately half of the patients who developed resistance to EGFR-TKIs treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxin, Wu, Xilin, Wang, Junhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362841/
https://www.ncbi.nlm.nih.gov/pubmed/35957876
http://dx.doi.org/10.3389/fonc.2022.898586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362841/
https://www.ncbi.nlm.nih.gov/pubmed/35957876
http://dx.doi.org/10.3389/fonc.2022.898586

Ejemplares similares